PERINDOPRIL ERBUMINE/ INDAPAMIDE
PERINDOPRIL ERBUMINE/ INDAPAMIDE
Approved
DIN Number
02479834
Drug Class
Human
Market Date
Jan 20, 2022
Company
HC
sivem pharmaceuticals ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02479834
AIG Number0248401001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09BA04 PERINDOPRIL AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.24
Health Canada Classification
ACTIVE INGREDIENTS (2)
INDAPAMIDEActive
Strength: 1.25 MG
Monograph: INDAPAMIDE
PERINDOPRIL ERBUMINEActive
Strength: 4 MG
Monograph: PERINDOPRIL ERBUMINE